Cargando…
Does price disclosure in pharmaceutical advertising result in price transparency? Evidence from a randomized experiment
BACKGROUND: Policies that mandate list price disclosure in direct-to-consumer pharmaceutical advertising (DTCPA) cite price transparency among the benefits. The expectation is that price transparency will lead to changes in consumer behavior that will ultimately lower healthcare costs. OBJECTIVE: Th...
Autores principales: | Hollin, Ilene L., Ball, Jennifer Gerard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526226/ https://www.ncbi.nlm.nih.gov/pubmed/36193449 http://dx.doi.org/10.1016/j.rcsop.2022.100180 |
Ejemplares similares
-
Enhancing medicine price transparency through price information mechanisms
por: Hinsch, Michael, et al.
Publicado: (2014) -
Proofs for PLOS ONE Paper : Does Pharmaceutical Pricing Transparency Matter? Examining Brazil’s Public Procurement System
por: Kohler, Jillian Clare, et al.
Publicado: (2015) -
Affordable Prices Without Threatening the Oncological R&D Pipeline—An Economic Experiment on Transparency in Price Negotiations
por: Franzen, Nora, et al.
Publicado: (2022) -
Are payors ready for transparent prices yet?
por: Barman-Aksözen, Jasmin
Publicado: (2022) -
Mohs Surgery Price Transparency and Variability at Academic Hospitals After the Implementation of the Federal Price Transparency Final Rule
por: Jain, Neelesh P, et al.
Publicado: (2023)